REGENESIS invites you to attend our upcoming Winter 2025 webinars. We will be featuring three webinar events with key environmental thought leaders. Topics will cover the link between Parkinson’s Disease and TCE exposure, in situ colloidal activated carbobn treatment for PFAS, and navigating PFAS regulations. Each webinar will provide an opportunity for questions and answers. Certificates of completion are available on request. Sign up for the upcoming webinars today!*
* NOTE: We encourage you to register even if you are unable to attend every event since you will receive each of the recordings following their scheduled broadcast dates.
Parkinson’s Disease Linked To Chlorinated Solvent Exposure on Large US Marine Base
Thursday, January 30th, 2025 | 11am pacific/2pm eastern
Samuel Goldman, MD, MPH, Professor in the Division of Occupational, Environmental, and Climate Medicine at the University of California San Francisco and author of Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune. His presentation will discuss the link to Parkinson’s Disease resulting from chlorinated solvent exposure on a large US Marine Base. He will be joined by Ryan Miller, Director of Land Science, who will discuss leading remediation and vapor mitigation technologies to protect against TCE exposure risk.
Samuel Goldman, MD, MPH
Professor, Division of Occupational, Environmental, and Climate Medicine, University of California San Francisco
Samuel Goldman, MD, MPH, is a Professor in the Division of Occupational, Environmental, and Climate Medicine at the University of California San Francisco. He is also an investigator at the San Francisco VA Health Care System, where he previously ran an Environmental Medicine clinic. Sam studied neuroscience at the University of Michigan, attended medical school at the University of Texas-Houston, and trained in Preventive Medicine and Environmental Health Science at UC Berkeley. He has published extensively on the epidemiology of Parkinson’s disease and other neurodegenerative disorders, with a focus on environmental risk factors such as pesticides, solvents, and head injury, and their interaction with genetic susceptibility factors.
Ryan Miller
Director, Land Science
Ryan Miller is the Director of the Land Science® division of REGENESIS, Inc., and is based in northern New Jersey. Ryan’s role includes providing technical support in the design and installation of TerraShield, Nitra-Seal, MonoShield and Retro-Coat vapor mitigation systems, and educating the environmental community on the advancements in vapor intrusion barrier technology, implementation, and quality control by making presentations to environmental firms, regulatory agencies, and developers. Ryan has extensive experience in the environmental consulting industry, most recently working as a New Jersey Licensed Site Remediation Professional (LSRP) focusing on brownfield redevelopment projects and specializing in vapor intrusion mitigation. Ryan earned a MBA from Montclair State University and a Bachelor of Science degree in Environmental Studies from Siena College.
PFAS Visualization Case Studies Demonstrate How to Improve Conceptual Site Models
Thursday, February 20th, 2025 | 11am pacific/2pm eastern
In this webinar we are pleased to have a special presentation by Grant Carey, PhD, President of Porewater Solutions. His presentation will discuss PFAS visualization case studies demonstrate how to improve conceptual site models.
Grant Carey, PhD
President, Porewater Solutions
Dr. Grant Carey is President of Porewater Solutions, and he has more than 30 years of experience focusing on the characterization and remediation of hundreds of impacted sites. Grant specializes in PFAS fate and remediation, environmental forensics, groundwater modeling, and visualization. Grant is involved with a number of SERDP and ESTCP projects with a focus on PFAS in-situ remediation modeling and visualization. Grant is also an Adjunct Research Professor at Carleton University in Ottawa, Canada and an Adjunct Professor at the University of Toronto.
Navigating PFAS Legal Challenges: Key TSCA and CERCLA Insights
Thursday, March 13th, 2025 | 11am pacific/2pm eastern
In this webinar we were pleased to have special guest speaker Brian D. Gross, Partner, at MG+M The Law Firm. His presentation will discuss the latest TSCA (Toxic Substances Control Act) PFAS reporting requirements, which govern the introduction and management of chemical substances to protect human health and the environment. He will also explore the legal and financial ramifications of EPA’s designation of PFOA and PFOS as “hazardous substances” under CERCLA and EPA’s promulgation of Maximum Contaminant Levels for PFAS in drinking water, as well as the legal challenges to these rules.
Brian D. Gross
Partner, MG+M The Law Firm
Brian Gross has an exceptional track record of finding client-oriented solutions to complex legal issues. Drawing on almost three decades of courtroom experience, he handles a broad spectrum of litigation, including environmental litigation, products liability, asbestos and other toxic tort litigation, pharmaceutical and medical device claims, and business disputes for clients across the United States. He is accomplished in the defense of both conventional and novel claims, including those involving per-and polyfluoroalkyl substances (PFAS). As counsel for several entities facing government enforcement and civil class actions relating to multiple contaminants, including PFAS, Brian develops strategies not only to eliminate or mitigate the liability of his clients, but also to recover the costs associated with investigation and remediation. In addition, Brian counsels clients concerning environmental contamination and potential liabilities that may arise from industrial, manufacturing and other processes. This includes the development of programs for compliance with federal, state and local environmental regulations and the counseling of companies and investment firms concerning environmental issues, including PFAS, for corporate transactions, investment decisions, and to avoid future litigation.